Form D · Biotechnology
POINTCARE TECHNOLOGIES INC
Marlborough, MA · CIK 0001384602
Offering snapshot reported Sep 23, 2010 · SEC filing
- Reported sold
- $1.77M Offering amount: $3.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2010 | Initial | $1,765,594 | No comparison | 3 | SEC filing |
| Jun 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-148114
Source: Form D, filed Sep 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Barry, Jr. | Executive |
| John Collins | Executive |
| Glen Jorgensen | Director |
| Petra Krauledat | Director, Executive |
| Clive R Landis | Director |
| Fred Morris | Director |
| Louis Pellegrine | Director |
| David Singh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
257 Simarano Drive
Marlborough, MA, 01752
Marlborough, MA, 01752